Recommendations for Mutational Analysis of Various Solid Tumors

Ezra Cohen, MD, FRCPSC, FASCO; Mary Jo Fidler, MD; Arturo Loaiza-Bonilla, MD, MSEd, FACP

Video Categories: NTRK Gene Fusions

Dr Ezra Cohen of UC San Diego, La Jolla, CA; Dr Mary Fidler Rush of University Medical Center, Chicago, IL; and Dr Arturo Loaiza-Bonilla of the Comprehensive Care and Research Center, Philadelphia, PA, explain which targetable mutation should be screened for various solid tumors.

December 3, 2013

The Role of Hedgehog Pathway Inhibition in Advanced Basal Cell Carcinoma

In the first WCMC clinical commentary entitled, The Role of Hedgehog Pathway Inhibition in Advanced Basal Cell Carcinoma, Dirk Schadendorf, MD; Nicole Basset-Seguin, MD, PhD; Aleksander Sekulic, MD, PhD discuss how the hedgehog pathway plays a critical role in developing basal cell carcinoma and how inhibitors are providing new strategies [ Read More ]

January 30, 2014

Communicating Value of Personalized Medicine to All Stakeholders in Healthcare

Listen as Dr Argawala articulates the value proposition of personalized medicine for all stakeholders in healthcare.